Inclisiran

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Inclisiran and local guidelines before prescribing.

siRNA lipid-lowering agent

Mechanism

Small interfering RNA reducing hepatic PCSK9 synthesis.

Uses

Hypercholesterolaemia above target on maximum tolerated statin.

Dosing

Side effects

Injection-site reactions, arthralgia, bronchitis.

Interactions

Few.

Contraindications and cautions

Hypersensitivity

Monitoring

Lipids

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

Twice-yearly injection after initial doses; used per NICE criteria.

More from the textbook: uses, cautions and other points
Where it is discussed in the book